<p>191 blood samples serially collected within 6 mo before (pre) or after (post) biopsy-confirmed AR were evaluated by kSORT. Frequencies of samples predicted as AR (red) or predicted as No-AR (green) were compared between sample collection time points (>3 mo prior to AR biopsy, <i>n</i> = 30; 0–3 mo prior to AR biopsy, <i>n</i> = 35; at AR biopsy, <i>n</i> = 74; 0–3 mo after AR biopsy, <i>n</i> = 31; >3 mo after AR biopsy, <i>n</i> = 21; and at No-AR/stable time points, <i>n</i> = 216). 62.86% of samples collected 0–3 mo (1.15±0.90 mo) prior to the AR biopsy had high probabilities for AR predicted by kSORT (96.36±0.08). High probabilities for AR persisted in 51.6% of samples collected 0–3 mo post-AR (94.60%±0.14); in comparison, 83.8% of t...
Biopsy-proven acute cellular rejection (ACR) is the primary efficacy endpoint in most randomized tri...
Post biopsy graft survival according to the C1q positivity in patients with AMR (A) and without AMR ...
We compared the breast core needle biopsy and the resection specimen with respect to estrogen (ER), ...
<p><b>A.</b> The predicted probability of a sample having a non-invasive diagnosis of AR, based on t...
The Kidney Solid Organ Response Test (kSORT) blood gene expression assay was developed to noninvasiv...
<p>(A) Independent validation of kSORT in 124 adult and pediatric AR and No-AR blood samples using t...
Development of noninvasive molecular assays to improve disease diagnosis and patient monitoring is a...
BackgroundDevelopment of noninvasive molecular assays to improve disease diagnosis and patient monit...
<p>(A) ABS levels plotted for all study participants. Acute rejection events as diagnosed by endomyo...
Abstract Background: Development of noninvasive molecular assays to improve disease diagnosis and pa...
<p><i>For all 86 samples in the prediction set, Sensitivity = 87%, Specificity = 90%.</i><sup></sup>...
Background: There are inconsistent findings regarding the relationship between trough whole blood ta...
<p>In analysis within ABOi+HLAs and HLAs group, prevalence of <b>(A)</b> AAMR and <b>(B)</b> overall...
Biopsy-proven acute cellular rejection (ACR) is the primary efficacy endpoint in most randomized tri...
Solid organ transplantation is a common procedure for end-stage organ failure. After the transplant...
Biopsy-proven acute cellular rejection (ACR) is the primary efficacy endpoint in most randomized tri...
Post biopsy graft survival according to the C1q positivity in patients with AMR (A) and without AMR ...
We compared the breast core needle biopsy and the resection specimen with respect to estrogen (ER), ...
<p><b>A.</b> The predicted probability of a sample having a non-invasive diagnosis of AR, based on t...
The Kidney Solid Organ Response Test (kSORT) blood gene expression assay was developed to noninvasiv...
<p>(A) Independent validation of kSORT in 124 adult and pediatric AR and No-AR blood samples using t...
Development of noninvasive molecular assays to improve disease diagnosis and patient monitoring is a...
BackgroundDevelopment of noninvasive molecular assays to improve disease diagnosis and patient monit...
<p>(A) ABS levels plotted for all study participants. Acute rejection events as diagnosed by endomyo...
Abstract Background: Development of noninvasive molecular assays to improve disease diagnosis and pa...
<p><i>For all 86 samples in the prediction set, Sensitivity = 87%, Specificity = 90%.</i><sup></sup>...
Background: There are inconsistent findings regarding the relationship between trough whole blood ta...
<p>In analysis within ABOi+HLAs and HLAs group, prevalence of <b>(A)</b> AAMR and <b>(B)</b> overall...
Biopsy-proven acute cellular rejection (ACR) is the primary efficacy endpoint in most randomized tri...
Solid organ transplantation is a common procedure for end-stage organ failure. After the transplant...
Biopsy-proven acute cellular rejection (ACR) is the primary efficacy endpoint in most randomized tri...
Post biopsy graft survival according to the C1q positivity in patients with AMR (A) and without AMR ...
We compared the breast core needle biopsy and the resection specimen with respect to estrogen (ER), ...